Advertisement
If you have a new account but are having problems posting or verifying your account, please email us on hello@boards.ie for help. Thanks :)
Hello all! Please ensure that you are posting a new thread or question in the appropriate forum. The Feedback forum is overwhelmed with questions that are having to be moved elsewhere. If you need help to verify your account contact hello@boards.ie
Hi there,
There is an issue with role permissions that is being worked on at the moment.
If you are having trouble with access or permissions on regional forums please post here to get access: https://www.boards.ie/discussion/2058365403/you-do-not-have-permission-for-that#latest

AbbVie Inc

  • 08-08-2014 12:34pm
    #1
    Mickey Dazzler
    Closed Accounts Posts: 586 ✭✭✭


    So.. I know one should not use tips as ones investment strategy however a trusted friend reckons after the Hep C drug comes out this stock should do well.

    Do any of you learned investors have any opinions?

    ABBV


Comments

  • #2
    RobertKK
    Registered Users, Registered Users 2 Posts: 33,761 ✭✭✭✭RobertKK


    I think GILD is still a way better investment than ABBV.

    One has to love the management of GILD, smashing earning reports, a great pipeline, leader in Hep C and HIV, growing at a phenomenal rate, share buy back and lots of cash for acquisitions.

    Just think there is only one way GILD shares will be going in the coming years.
    ABBV are lagging behind and I read their Hep C drug is a problem for 10% of users who suffer liver damage, unlike GILD's Sovaldi.


  • #3
    zpehtsfd
    Registered Users, Registered Users 2 Posts: 627 ✭✭✭zpehtsfd


    Mickey Dazzler wrote: »
    So.. I know one should not use tips as ones investment strategy however a trusted friend reckons after the Hep C drug comes out this stock should do well.

    Do any of you learned investors have any opinions?ABBV

    If you believe their Hep C drug will be successful then you could also look into investing in ENTA (ABBVs Hep C partner).

    Here's a valuation model for ENTA.

    http://investorshub.advfn.com/boards/read_msg.aspx?message_id=94993406

    If you have questions and wish to contact this poster then the easiest way is via twitter @DewDiligence

    GL


Advertisement